This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Mar;10(3):127.

doi: 10.1038/nrendo.2013.266. Epub 2014 Jan 7.

Pharmacotherapy: a new option for Cushing disease?

PMID: 24393783
DOI: 10.1038/nrendo.2013.266

Comment

Pharmacotherapy: a new option for Cushing disease?

Vicky Heath. Nat Rev Endocrinol. 2014 Mar.

. 2014 Mar;10(3):127.

doi: 10.1038/nrendo.2013.266. Epub 2014 Jan 7.

Author

PMID: 24393783
DOI: 10.1038/nrendo.2013.266

No abstract available

PubMed Disclaimer

Comment on

LCI699, a potent 11β-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study.
Bertagna X, Pivonello R, Fleseriu M, Zhang Y, Robinson P, Taylor A, Watson CE, Maldonado M, Hamrahian AH, Boscaro M, Biller BM. Bertagna X, et al. J Clin Endocrinol Metab. 2014 Apr;99(4):1375-83. doi: 10.1210/jc.2013-2117. Epub 2013 Dec 11. J Clin Endocrinol Metab. 2014. PMID: 24423285 Clinical Trial.

References

1. J Clin Endocrinol Metab. 2014 Apr;99(4):1375-83 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations